BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6894852)

  • 1. Abnormal platelet function in myeloproliferative disorders.
    Waddell CC; Brown JA; Repinecz YA
    Arch Pathol Lab Med; 1981 Aug; 105(8):432-5. PubMed ID: 6894852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts?
    Grignani C; Noris P; Tinelli C; Barosi G; Balduini CL
    Platelets; 2009 Mar; 20(2):131-4. PubMed ID: 19235056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders.
    Yamamoto K; Sekiguchi E; Takatani O
    Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
    Murphy S; Davis JL; Walsh PN; Gardner FH
    Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal aggregation and increased size of platelets in myeloproliferative disorders.
    Cortelazzo S; Barbui T; Bassan R; Dini E
    Thromb Haemost; 1980 Jun; 43(2):127-30. PubMed ID: 7455970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of platelet aggregation abnormalities in thrombocytosis after thrombocytopheresis.
    Fabris F; Belloni M; Casonato A; Randi M; Ongaro G; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):853-62. PubMed ID: 6176511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
    Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
    Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder.
    Handa M; Watanabe K; Kawai Y; Kamata T; Koyama T; Nagai H; Ikeda Y
    Thromb Haemost; 1995 Mar; 73(3):521-8. PubMed ID: 7667837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The platelet defect in myeloproliferative disorder (author's transl)].
    Delobel J
    Nouv Rev Fr Hematol (1978); 1976; 16(3):443-6. PubMed ID: 1012918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
    Zuk E
    Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet function in chronic myeloproliferative syndromes associated with thrombocytosis].
    Grebe G; Pereira J; Mezzano D; Legues ME; Aranda E; Lira P
    Rev Med Chil; 1985 Jan; 113(1):32-7. PubMed ID: 4081383
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet abnormalities in myeloproliferative disorders.
    Holme S; Murphy S
    Clin Lab Med; 1990 Dec; 10(4):873-88. PubMed ID: 2272179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leg pain and platelet aggregates in thrombocythemic myeloproliferative disease.
    Salem HH; van der Weyden MB; Koutts J; Firkin BG
    JAMA; 1980 Sep; 244(10):1122-3. PubMed ID: 7411766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The assessment of platelet function in patients with essential thrombocythemia].
    TreliƄski J; Tybura M; Chojnowski K
    Pol Merkur Lekarski; 2008 Jul; 25(145):19-22. PubMed ID: 18839608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregation in platelet-rich plasma and whole blood in 120 patients with myeloproliferative disorders.
    Balduini CL; Bertolino G; Noris P; Piletta GC
    Am J Clin Pathol; 1991 Jan; 95(1):82-6. PubMed ID: 1987755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet function tests using platelet aggregometry: need for repetition of the test for diagnosis of defective platelet function.
    Ghosh K; Nair S; Kulkarni B; Khare A; Shetty S; Mohanty D
    Platelets; 2003 Sep; 14(6):351-4. PubMed ID: 14602548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of bleeding time, platelet aggregation and platelet count during CAPD treatment.
    Arends JP; Krediet RT; Boeschoten EW; van der Lelie J; Veenhof CH; von dem Borne AE
    Proc Eur Dial Transplant Assoc; 1981; 18():280-5. PubMed ID: 7329972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a platelet membrane defect in the myeloproliferative syndromes.
    Castaldi PA; Berndt MC; Booth W; Gregory C; Bull H; Greaves M
    Thromb Res; 1982 Sep; 27(5):601-9. PubMed ID: 6960545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
    Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
    Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased platelet aggregation following splenectomy in patients with myeloproliferative disease.
    Aviram M; Carter A; Tatarsky I; Levy Y; Brook JG
    Isr J Med Sci; 1985 May; 21(5):415-7. PubMed ID: 4019124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.